Biomarkers in aneurysmal subarachnoid hemorrhage: A short review

Poor outcomes of aneurysmal subarachnoid hemorrhage (aSAH) can be the result of the initial catastrophic event or the many acute or delayed neurological complications. Recent evidence suggests that some molecules play a critical role in both events, through some unknown pathways involved. Understand...

Descripción completa

Detalles Bibliográficos
Autores principales: Batista, Sávio, Bocanegra-Becerra, Jhon E., Claassen, Bernardo, Rubião, Felipe, Rabelo, Nicollas Nunes, Figueiredo, Eberval Gadelha, Oberman, Dan Zimelewicz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Literature Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189293/
https://www.ncbi.nlm.nih.gov/pubmed/37206060
http://dx.doi.org/10.1016/j.wnsx.2023.100205
Descripción
Sumario:Poor outcomes of aneurysmal subarachnoid hemorrhage (aSAH) can be the result of the initial catastrophic event or the many acute or delayed neurological complications. Recent evidence suggests that some molecules play a critical role in both events, through some unknown pathways involved. Understanding the role of these molecules in these events could allow to improve diagnostic accuracy, guide management, and prevent long-term disability in aSAH. Here we present the studies on aSAH biomarkers present in current medical literature, highlighting their roles and main results.

Ejemplares similares